TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Mar 15, 2024 | Option Exercise | $8.64 | 2,704 | 23,363 | 1,561,473 | Mar 19, 2024, 06:06 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 20, 2024 | Option Exercise | $8.92 | 37,196 | 331,788 | 1,558,769 | Feb 22, 2024, 08:14 PM |
TBPH | | Theravance Biopharma, Inc. | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Feb 20, 2024 | Option Exercise | $8.92 | 17,036 | 151,961 | 238,636 | Feb 22, 2024, 08:11 PM |
TBPH | | Theravance Biopharma, Inc. | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Feb 20, 2024 | Option Exercise | $8.92 | 11,782 | 105,095 | 133,534 | Feb 22, 2024, 08:10 PM |
TBPH | | Theravance Biopharma, Inc. | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Feb 20, 2024 | Option Exercise | $8.92 | 17,595 | 156,947 | 260,684 | Feb 22, 2024, 08:08 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Feb 20, 2024 | Option Exercise | $8.92 | 19,294 | 172,102 | 314,915 | Feb 22, 2024, 08:06 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 20, 2024 | Option Exercise | $8.92 | 18,219 | 162,513 | 312,987 | Feb 22, 2024, 08:04 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 22, 2024 | Sale | $8.71 | 1,254 | 10,922 | 311,733 | Feb 22, 2024, 08:04 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 20, 2023 | Option Exercise | $10.37 | 15,804 | 163,887 | 1,595,965 | Nov 22, 2023, 06:16 PM |
TBPH | | Theravance Biopharma, Inc. | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Nov 20, 2023 | Option Exercise | $10.37 | 6,187 | 64,159 | 255,672 | Nov 22, 2023, 06:14 PM |
TBPH | | Theravance Biopharma, Inc. | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Nov 20, 2023 | Option Exercise | $10.37 | 7,363 | 76,354 | 278,279 | Nov 22, 2023, 06:11 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 20, 2023 | Option Exercise | $10.37 | 12,630 | 130,973 | 334,209 | Nov 22, 2023, 06:10 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 20, 2023 | Option Exercise | $10.37 | 7,982 | 82,773 | 332,584 | Nov 22, 2023, 06:07 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 21, 2023 | Sale | $10.29 | 1,378 | 14,180 | 331,206 | Nov 22, 2023, 06:07 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 14, 2023 | Sale | $10.22 | 2,482 | 25,366 | 346,839 | Nov 16, 2023, 06:16 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Oct 16, 2023 | Sale | $9.03 | 2,482 | 22,412 | 334,321 | Oct 18, 2023, 06:54 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Sep 14, 2023 | Sale | $9.89 | 2,482 | 24,547 | 336,803 | Sep 18, 2023, 06:08 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 22, 2023 | Sale | $9.47 | 1,807 | 17,112 | 340,566 | Aug 24, 2023, 06:05 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Aug 20, 2023 | Option Exercise | $9.70 | 15,804 | 153,299 | 1,611,769 | Aug 22, 2023, 06:19 PM |
TBPH | | Theravance Biopharma, Inc. | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Aug 20, 2023 | Option Exercise | $9.70 | 7,114 | 69,006 | 261,859 | Aug 22, 2023, 06:17 PM |
TBPH | | Theravance Biopharma, Inc. | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Aug 20, 2023 | Option Exercise | $9.70 | 8,912 | 86,446 | 285,297 | Aug 22, 2023, 06:15 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Aug 20, 2023 | Option Exercise | $9.70 | 10,461 | 101,472 | 339,285 | Aug 22, 2023, 06:13 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 20, 2023 | Option Exercise | $9.70 | 10,460 | 101,462 | 342,373 | Aug 22, 2023, 06:10 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Aug 11, 2023 | Sale | $9.99 | 2,322 | 23,197 | 349,746 | Aug 15, 2023, 06:09 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Jul 14, 2023 | Sale | $9.84 | 2,322 | 22,848 | 352,068 | Jul 18, 2023, 06:14 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Jun 14, 2023 | Sale | $10.69 | 2,322 | 24,822 | 354,390 | Jun 16, 2023, 06:14 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Jun 08, 2023 | Sale | $11.13 | 1,790 | 19,923 | 352,833 | Jun 12, 2023, 06:08 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | May 20, 2023 | Option Exercise | $11.21 | 15,804 | 177,163 | 1,627,573 | May 23, 2023, 07:48 PM |
TBPH | | Theravance Biopharma, Inc. | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | May 20, 2023 | Option Exercise | $11.21 | 8,744 | 98,020 | 268,973 | May 23, 2023, 07:46 PM |
TBPH | | Theravance Biopharma, Inc. | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | May 20, 2023 | Option Exercise | $11.21 | 11,469 | 128,567 | 294,209 | May 23, 2023, 07:44 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | May 20, 2023 | Option Exercise | $11.21 | 10,460 | 117,257 | 356,712 | May 23, 2023, 07:41 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 20, 2023 | Option Exercise | $11.21 | 5,567 | 62,406 | 354,623 | May 23, 2023, 07:40 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | May 15, 2023 | Sale | $11.26 | 2,322 | 26,146 | 367,172 | May 17, 2023, 06:17 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Apr 14, 2023 | Sale | $11.88 | 2,323 | 27,597 | 369,494 | Apr 18, 2023, 05:49 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Mar 14, 2023 | Sale | $10.32 | 2,323 | 23,973 | 371,817 | Mar 16, 2023, 07:04 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Mar 09, 2023 | Sale | $10.20 | 4,000 | 40,800 | 360,190 | Mar 13, 2023, 05:57 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Mar 06, 2023 | Sale | $10.05 | 2,323 | 23,346 | 374,140 | Mar 08, 2023, 07:34 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 20, 2023 | Option Exercise | $10.44 | 37,420 | 390,665 | 1,313,377 | Feb 22, 2023, 07:29 PM |
TBPH | | Theravance Biopharma, Inc. | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Feb 20, 2023 | Option Exercise | $10.44 | 6,783 | 70,815 | 197,717 | Feb 22, 2023, 07:27 PM |
TBPH | | Theravance Biopharma, Inc. | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Feb 20, 2023 | Option Exercise | $10.44 | 10,198 | 106,467 | 229,958 | Feb 22, 2023, 07:23 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Feb 20, 2023 | Option Exercise | $10.44 | 12,057 | 125,875 | 301,463 | Feb 22, 2023, 07:21 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 20, 2023 | Option Exercise | $10.44 | 7,119 | 74,322 | 289,190 | Feb 22, 2023, 07:18 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Dec 14, 2022 | Sale | $11.19 | 50,000 | 559,500 | 1,350,797 | Dec 16, 2022, 07:36 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Dec 01, 2022 | Sale | $10.73 | 2,084 | 22,361 | 313,520 | Dec 05, 2022, 05:59 PM |
TBPH | | Theravance Biopharma, Inc. | O'Connor Donal | Director | Nov 22, 2022 | Option Exercise | $10.50 | 10,000 | 105,000 | 43,886 | Nov 23, 2022, 06:57 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 20, 2022 | Option Exercise | $10.85 | 15,804 | 171,473 | 1,409,797 | Nov 22, 2022, 04:09 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 18, 2022 | Sale | $11.02 | 65,000 | 716,242 | 409,771 | Nov 22, 2022, 04:07 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 20, 2022 | Option Exercise | $10.85 | 25,057 | 271,868 | 384,714 | Nov 22, 2022, 04:07 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 20, 2022 | Option Exercise | $10.85 | 27,350 | 296,748 | 315,604 | Nov 22, 2022, 04:04 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 20, 2022 | Option Exercise | $10.85 | 23,268 | 252,458 | 296,309 | Nov 22, 2022, 04:02 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 16, 2022 | Option Exercise | $11.20 | 2,800 | 31,360 | 342,954 | Nov 17, 2022, 07:53 PM |
TBPH | | Theravance Biopharma, Inc. | GSK PLC | Former 10% Owner | Sep 16, 2022 | Option Exercise | $9.75 | 9,644,807 | 94,036,868 | 0 | Sep 20, 2022, 04:16 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Aug 19, 2022 | Option Exercise | $9.34 | 15,804 | 147,609 | 1,424,784 | Aug 23, 2022, 07:03 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Aug 19, 2022 | Option Exercise | $9.34 | 25,676 | 239,814 | 473,507 | Aug 23, 2022, 07:00 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 19, 2022 | Option Exercise | $9.34 | 18,991 | 177,376 | 345,754 | Aug 23, 2022, 06:57 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 19, 2022 | Option Exercise | $9.34 | 10,413 | 97,257 | 319,577 | Aug 23, 2022, 06:54 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 16, 2022 | Sale | $9.71 | 4,906 | 47,640 | 364,745 | Aug 18, 2022, 06:05 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 09, 2022 | Sale | $8.79 | 15,086 | 132,606 | 369,651 | Aug 11, 2022, 06:55 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | May 20, 2022 | Option Exercise | $8.74 | 11,025 | 96,358 | 1,440,588 | May 24, 2022, 07:19 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | May 20, 2022 | Option Exercise | $8.74 | 3,365 | 29,410 | 479,183 | May 24, 2022, 07:17 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | May 20, 2022 | Option Exercise | $8.74 | 3,947 | 34,497 | 384,737 | May 24, 2022, 07:14 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 23, 2022 | Sale | $8.93 | 1,081 | 9,653 | 329,990 | May 24, 2022, 07:11 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 20, 2022 | Option Exercise | $8.74 | 2,200 | 19,228 | 331,071 | May 24, 2022, 07:11 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 28, 2022 | Sale | $10.16 | 2,356 | 23,947 | 333,271 | Mar 02, 2022, 07:08 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 18, 2022 | Option Exercise | $9.61 | 22,710 | 218,243 | 1,279,300 | Feb 23, 2022, 06:38 PM |
TBPH | | Theravance Biopharma, Inc. | PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | Feb 18, 2022 | Option Exercise | $9.61 | 27,299 | 262,343 | 380,123 | Feb 23, 2022, 06:34 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Feb 18, 2022 | Option Exercise | $9.61 | 25,973 | 249,601 | 481,285 | Feb 23, 2022, 06:29 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | Feb 18, 2022 | Option Exercise | $9.61 | 20,377 | 195,823 | 388,684 | Feb 23, 2022, 06:25 PM |
TBPH | | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 18, 2022 | Option Exercise | $9.61 | 11,824 | 113,629 | 335,627 | Feb 23, 2022, 06:22 PM |
TBPH | | Theravance Biopharma, Inc. | BRADY ANN | PRESIDENT, TBIL | Feb 18, 2022 | Option Exercise | $9.61 | 8,369 | 80,426 | 110,319 | Feb 23, 2022, 06:18 PM |
TBPH | | Theravance Biopharma, Inc. | BRADY ANN | PRESIDENT, TBIL | Nov 19, 2021 | Option Exercise | $8.36 | 3,169 | 26,493 | 118,688 | Nov 23, 2021, 08:26 PM |
TBPH | | Theravance Biopharma, Inc. | PASQUALONE FRANK | SVP, CHIEF BUSINESS OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 3,779 | 31,592 | 429,783 | Nov 23, 2021, 08:25 PM |
TBPH | | Theravance Biopharma, Inc. | PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | Nov 19, 2021 | Option Exercise | $8.36 | 4,310 | 36,032 | 355,422 | Nov 23, 2021, 08:24 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | Nov 19, 2021 | Option Exercise | $8.36 | 4,263 | 35,639 | 169,061 | Nov 23, 2021, 08:23 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 1,350 | 11,286 | 167,258 | Nov 23, 2021, 08:22 PM |
TBPH | | Theravance Biopharma, Inc. | WORBOYS PHILIP D | SVP, RESEARCH & TRANSL SCIENCE | Nov 19, 2021 | Option Exercise | $8.36 | 4,310 | 36,032 | 330,752 | Nov 23, 2021, 08:21 PM |
TBPH | | Theravance Biopharma, Inc. | SABESAN VIJAY | SVP, TECHNICAL OPERATIONS | Nov 19, 2021 | Option Exercise | $8.36 | 5,191 | 43,397 | 235,524 | Nov 23, 2021, 08:21 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 11,404 | 95,337 | 1,302,010 | Nov 23, 2021, 08:20 PM |
TBPH | | Theravance Biopharma, Inc. | WORBOYS PHILIP D | SVP, Research & Transl Science | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 335,062 | Aug 24, 2021, 07:07 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | Chief Executive Officer | Aug 20, 2021 | Option Exercise | $14.05 | 11,404 | 160,226 | 1,313,414 | Aug 24, 2021, 07:05 PM |
TBPH | | Theravance Biopharma, Inc. | Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 277,831 | Aug 24, 2021, 07:03 PM |
TBPH | | Theravance Biopharma, Inc. | SABESAN VIJAY | SVP, Technical Operations | Aug 20, 2021 | Option Exercise | $14.05 | 5,193 | 72,962 | 240,715 | Aug 24, 2021, 07:01 PM |
TBPH | | Theravance Biopharma, Inc. | PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 359,732 | Aug 24, 2021, 06:59 PM |
TBPH | | Theravance Biopharma, Inc. | PASQUALONE FRANK | SVP, Chief Business Officer | Aug 20, 2021 | Option Exercise | $14.05 | 3,779 | 53,095 | 433,562 | Aug 24, 2021, 06:57 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, Chief Financial Officer | Aug 20, 2021 | Option Exercise | $14.05 | 17,464 | 245,369 | 167,380 | Aug 24, 2021, 06:55 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, Development | Aug 20, 2021 | Option Exercise | $14.05 | 6,819 | 95,807 | 173,205 | Aug 24, 2021, 06:52 PM |
TBPH | | Theravance Biopharma, Inc. | BRADY ANN | President, TBIL | Aug 20, 2021 | Option Exercise | $14.05 | 3,169 | 44,524 | 121,857 | Aug 24, 2021, 06:50 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | Chief Executive Officer | May 20, 2021 | Option Exercise | $17.80 | 11,404 | 202,991 | 1,324,818 | May 24, 2021, 06:19 PM |
TBPH | | Theravance Biopharma, Inc. | Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2021 | Option Exercise | $17.80 | 4,310 | 76,718 | 282,138 | May 24, 2021, 06:18 PM |
TBPH | | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, Development | May 20, 2021 | Option Exercise | $17.80 | 3,410 | 60,698 | 180,024 | May 24, 2021, 06:09 PM |
TBPH | | Theravance Biopharma, Inc. | BRADY ANN | President, TBIL | May 20, 2021 | Option Exercise | $17.80 | 3,169 | 56,408 | 125,026 | May 24, 2021, 06:07 PM |
TBPH | | Theravance Biopharma, Inc. | WORBOYS PHILIP D | SVP, Research & Transl Science | Mar 09, 2021 | Sale | $20.00 | 8,829 | 176,580 | 343,679 | Mar 11, 2021, 07:00 PM |
TBPH | | Theravance Biopharma, Inc. | WORBOYS PHILIP D | SVP, Research & Transl Science | Feb 20, 2021 | Option Exercise | $18.79 | 31,887 | 599,157 | 352,508 | Feb 23, 2021, 06:20 PM |
TBPH | | Theravance Biopharma, Inc. | Winningham Rick E | Chief Executive Officer | Feb 20, 2021 | Option Exercise | $18.79 | 110,348 | 2,073,439 | 1,334,821 | Feb 23, 2021, 06:17 PM |
TBPH | | Theravance Biopharma, Inc. | Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2021 | Option Exercise | $18.79 | 31,869 | 598,819 | 285,047 | Feb 23, 2021, 06:15 PM |
TBPH | | Theravance Biopharma, Inc. | SABESAN VIJAY | SVP, Technical Operations | Feb 20, 2021 | Option Exercise | $18.79 | 8,343 | 156,765 | 249,701 | Feb 23, 2021, 06:13 PM |
TBPH | | Theravance Biopharma, Inc. | PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2021 | Option Exercise | $18.79 | 31,931 | 599,984 | 368,349 | Feb 23, 2021, 06:10 PM |
TBPH | | Theravance Biopharma, Inc. | PASQUALONE FRANK | SVP, Chief Business Officer | Feb 20, 2021 | Option Exercise | $18.79 | 26,961 | 506,597 | 439,719 | Feb 23, 2021, 06:09 PM |
TBPH | | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, Chief Financial Officer | Feb 20, 2021 | Option Exercise | $18.79 | 3,984 | 74,859 | 184,704 | Feb 23, 2021, 06:07 PM |
TBPH | | Theravance Biopharma, Inc. | HAUMANN BRETT K | Chief Medical Officer | Feb 20, 2021 | Option Exercise | $18.79 | 35,672 | 670,277 | 242,499 | Feb 23, 2021, 06:05 PM |